代谢组
普氏粪杆菌
微生物群
结直肠癌
生物
基因组
肠道微生物群
代谢组学
腺瘤
粪便
结直肠腺瘤
肠道菌群
内科学
生理学
结肠镜检查
胃肠病学
癌症研究
组学
生物信息学
癌症
结直肠癌筛查
全基因组测序
转录组
管状腺瘤
生物标志物
肠道细菌
肠道准备
作者
Ana Nogal,Kai Wang,Kelsey N. Thompson,Hanseul Kim,Amrisha Bhosle,Gianmarco Piccinno,Sagun Maharjan,C. R. Upreti,Long Hoang Nguyen,Nicola Segata,Eric B. Rimm,Wendy S. Garrett,Andrew Tan Chan,Curtis Huttenhower,Mingyang Song
标识
DOI:10.1016/j.chom.2026.05.001
摘要
Although the gut microbiome is implicated in colorectal cancer (CRC), microbiome and metabolome alterations along the adenoma-carcinoma sequence remain unclear. Here, we profile stool metagenomes obtained from 354 women 12.1 ± 4.8 years following adenoma resection and from their 1:1-matched controls, as well as stool metabolomes from 184 pairs. Metagenomic profiles are compared with those from 14 independent CRC case-control studies. Microbial composition differs between adenoma cases and controls and agrees with CRC-associated alterations (Pearson's rho = 0.26, p < 0.0001). Thirty-one microbes, including Faecalibacterium prausnitzii and Flavonifractor plautii, are altered in both conditions and correlate with lifestyle factors. Thirty metabolites and 7 sub-pathways, particularly sphingolipids, are associated with adenomas. Adenomas also exhibit disease-specific microbe-metabolite associations, including those between Bilophila wadsworthia and alanine-containing dipeptides. These findings reveal gut microbial and metabolomic alterations detectable years after adenoma resection, supporting the presence of an altered microbiome along the adenoma-CRC continuum.
科研通智能强力驱动
Strongly Powered by AbleSci AI